Bastet 101



NASH initiation and progression is very complex.


Blocking multiple pathways will increase efficacy across a diverse population and disease pathogenisis.

Inhibits lipid synthesis by regulating the SREP1 pathway


Accelerates lipid oxidation/breakdown by binding PPAR-alpha which can modulate PPAR-gamma


Inhibits inflammation



Mitigates oxidative stress by having strong anti-oxidant activity


Print Print | Sitemap
© Bast Biotechnology - Powered by IONOS